AcquiredStartups
Home/Global/Healthtech & bio
Acquisition · Healthtech & bio ·

Commure acquires Elaborate to automate the clinician inbox

Elaborate's software sorts and answers patient portal messages inside the health record; Commure says health systems using it cut inbox time by up to 36%.

ASAcquired deals deskGlobal16 November 2026 · 3 min read
Commure acquires Elaborate
Image: Elaborate

Commure, a Mountain View, California company that sells AI software to hospitals and medical practices, said on November 16, 2026 that it has acquired Elaborate, a clinical intelligence platform built to reduce the stream of patient messages that reaches doctors after appointments. Terms of the transaction were not disclosed.

Elaborate is now described as a Commure company. Commure said the product is available immediately, either on its own or alongside Commure's ambient documentation, medical coding and revenue cycle tools, and that its forward-deployed engineering teams will work with each customer to tune Elaborate's protocols to how its clinicians practise.

Elaborate was founded and is led by chief executive Nicole Bocskocsky, who was quoted in the announcement. Neither company said how many people work at Elaborate or what roles its team will take inside Commure.

What Elaborate built

Elaborate works inside the electronic health record. According to Commure, it helps patients understand their care before they feel the need to send a message, sends the messages that do arrive to the right member of the care team, and automates routine clinical workflows using protocols that each organisation's own clinicians set and control.

On its website, Elaborate Health Inc. says the platform runs rules-based protocols across more than 30 ambulatory specialties, that those protocols have been validated across millions of real patient interactions, and that it is listed in the Epic Showroom and the Athena Marketplace, which simplifies deployment for hospitals on those record systems. The site also highlights a strategic partnership with Cedars-Sinai.

Commure said health systems using Elaborate have seen up to 36% less time spent in the inbox, a 15% drop in patient message volume and 97% clinician agreement with the automated actions. Those figures come from the companies and have not been independently checked, as Dealroom noted in its report on the deal.

“Clinicians spend twice as much time on documentation and billing as they do with patients, and LLMs finally take that work off them. Nicole and the Elaborate team built the agent that clears the inbox.”Tanay Tandon, Co-Founder and CEO, Commure

Why Commure is buying

The inbox has become one of the main sources of after-hours work for doctors. Commure said patient portal messages per patient rose 153% between 2020 and 2025, much faster than the growth in office visits, and that clinicians carry much of that work into evenings and weekends.

Commure's pitch is a single system that covers a patient's journey from the first phone call to the insurance claim. Its software already takes calls, handles referral intake, writes clinical notes, codes claims and manages denials. Elaborate adds the step after the visit.

"Clinicians spend twice as much time on documentation and billing as they do with patients, and LLMs finally take that work off them," said Tanay Tandon, Commure's co-founder and chief executive. He said Commure handles tens of millions of appointments a year and that combining the two products could reach tens of thousands of active clinicians on its platform from the first day.

Bocskocsky said Elaborate had shown that, with the right clinical context and safeguards, complex clinical tasks can be automated in a way clinicians overwhelmingly agree with, and that the deal lets the company pursue its founding mission of curing the inbox at a national scale.

Commure's scale and recent deals

Commure says it is live in more than 500 healthcare organisations, from HCA Healthcare to independent practices, with more than 500,000 users and about 7% of American healthcare appointments running through its software. Dealroom reported that the company is valued at about $7 billion.

The company has grown partly through acquisitions. Dealroom noted that Elaborate follows Commure's 2024 purchase of care-navigation platform Memora Health and a $70 million fundraise in May. Commure did not say whether more deals are planned.

Elaborate's funding history and founding date were not disclosed in the announcement.

What happens to customers

Health systems that already use Elaborate keep the product, which Commure said remains available across specialties to both large health systems and smaller practices. Commure customers can now add the inbox tools to the rest of their Commure deployment.

Commure describes its strategy as giving providers one trusted system of work instead of a dozen point solutions. The Elaborate deal tests that approach in a new area: the messages that arrive after the patient has gone home, which until now sat outside Commure's products.

Sources